Pharma Stocks
-
Merck & Co. (MRK) 2026 Analysis: Navigating the Keytruda Cliff with Pipeline-Driven Resilience
As of March 25, 2026, Merck & Co., Inc. (NYSE: MRK) stands at a pivotal crossroads in its 135-year history.…
Read More » -
The Bull Case For Amylyx Pharmaceuticals (AMLX) Could Change Following LUCIDITY Phase 3 Enrollment Completion
Amylyx Pharmaceuticals recently completed enrollment in its pivotal Phase 3 LUCIDITY trial of avexitide for post-bariatric hypoglycemia, a 16-week, randomized,…
Read More » -
Recordati S.p.A. stock faces pressure amid rare disease drug pipeline scrutiny and European pharma s
The Recordati S.p.A. stock (ISIN: IT0003828271) trades on the Milan Stock Exchange in euros, showing limited movement in recent sessions…
Read More » -
Rockwell Automation Pharma Win Highlights Digital Growth And Valuation Tension
Rockwell Automation (NYSE:ROK), together with Rovi and Adasoft, has rolled out a digital, paperless batch execution system for pharmaceutical production.…
Read More » -
Cardinal Health (CAH) Surged Following Improved Specialty Mix in Pharma
Brown Advisory, an investment management company, released its “Brown Advisory Mid-Cap Growth Strategy” fourth-quarter 2025 investor letter. A copy of the…
Read More » -
Simulations Plus stock gains momentum amid AI-driven drug discovery boom
The Simulations Plus stock (ISIN: US82834F1012) is drawing investor attention as pharmaceutical companies accelerate AI integration in drug development pipelines.…
Read More » -
Pfizer Receives Unsolicited Mini-Tender Offer for 1 Million Shares from Tutanota: Report
Pfizer issued a warning to it’s shareholders to not to participate in an unsolicited mini-tender offer from a company called…
Read More » -
Sanofi S.A. stock faces pressure amid China supply chain shifts in pharma sector peers
Sanofi S.A. (ISIN: FR0000127771) shares test key supports as semiconductor peers like STMicroelectronics advance China localization, raising questions for European…
Read More » -
Earnings due 24 Mar: NWRN.SW Newron Pharmaceuticals S.p.A. (SIX) pipeline test
The NWRN.SW stock trades intraday at CHF 15.40 as investors prepare for Newron Pharmaceuticals S.p.A.’s earnings on 24 Mar 2026.…
Read More » -
Mankind Pharma Ltd Falls to 52-Week Low of Rs 1929.55 as …
Price Action and Market Context The stock’s fall comes as the Pharmaceuticals & Biotechnology sector itself has declined by 3.09%…
Read More »